Search "peptides for weight loss" and you'll find two completely different worlds wearing the same name. One is a class of FDA-approved prescription medications — the GLP-1 receptor agonists — with published clinical trials, defined manufacturing, and licensed clinicians prescribing them. The other is a sprawl of online vendors selling unapproved "research peptides" in vials labeled not for human consumption, marketed with before-and-after photos and none of the accountability.
The short version: the only peptide-class medications with FDA approval for chronic weight management are GLP-1 receptor agonists — semaglutide (Wegovy®) and tirzepatide (Zepbound®). Everything else sold online as a "weight loss peptide" is, as of this writing, either an unapproved research compound or an investigational drug you cannot legally buy. This guide separates the two worlds, honestly.
"Peptide" is chemistry, not a credential
A peptide is just a short chain of amino acids. Insulin is a peptide. Semaglutide is a peptide — GLP-1 stands for glucagon-like peptide-1. Being "a peptide" says nothing about whether a product is approved, effective, or legal. The question that matters is: FDA-approved drug, or unapproved research compound?
The peptide-class medications that actually have evidence: GLP-1s
When people ask "do peptides work for weight loss," the accurate answer is: one family of them does, and it's probably not the one the vendor sites are selling.
GLP-1 receptor agonists mimic glucagon-like peptide-1, a gut hormone involved in appetite and blood sugar regulation. Two are FDA-approved specifically for chronic weight management in adults, on top of lifestyle changes:
- Semaglutide — approved as Wegovy® (Novo Nordisk) for chronic weight management, and as Ozempic® for type 2 diabetes.
- Tirzepatide — approved as Zepbound® (Eli Lilly) for chronic weight management, and as Mounjaro® for type 2 diabetes. Tirzepatide is technically a dual GLP-1/GIP receptor agonist — still peptide-class.
These medications went through the full FDA approval process: large randomized controlled trials, defined manufacturing standards, labeled dosing, and post-market safety monitoring. That is what separates them from everything else in this article. For a deeper comparison of the two molecules, see semaglutide vs. tirzepatide.
They are also prescription-only for a reason: eligibility is determined by a licensed clinician based on your health history, and certain conditions rule them out. A seller that skips that review isn't a shortcut — it's a red flag.
The "weight loss peptides" sold online: what the evidence actually says
The compounds most heavily marketed as weight-loss or body-composition peptides — names like BPC-157, AOD-9604, ipamorelin, CJC-1295, tesamorelin, and MOTS-c — share a common profile:
- None is FDA-approved for weight loss. Most aren't FDA-approved for anything.
- None is legally available through pharmacy compounding. They aren't on the FDA's list of substances allowed for compounding, which is why they're sold with "research use only" labels — a label that shifts legal risk to you rather than making the product legitimate.
- Human evidence for weight loss is not established. What exists is mostly animal data, small early-phase studies, or nothing at all in the peer-reviewed literature.
You'll also see retatrutide marketed by some vendors. Retatrutide is an investigational medication in clinical trials — it is not FDA-approved and is not legally available outside those trials, so anything sold online under that name is unregulated by definition.
We wrote a full plain-English guide to the legal side of this — 503A vs. 503B compounding, the FDA bulks list, and what's changing — in Are peptides legal? FDA rules explained. The one-line summary: the regulatory status of these compounds isn't a technicality. It's the difference between a medication prepared by a licensed, inspected pharmacy against a prescription, and a vial of unverified powder from a website that disclaims human use on the label.
Red flags, in order of importance
No prescription required. "Research use only" or "not for human consumption" labels. No named, licensed pharmacy. No licensed clinician anywhere in the process. Payment by wire, crypto, or app only. Any one of these is disqualifying — regardless of price, reviews, or how scientific the website looks.
Where does sermorelin fit?
Sermorelin comes up in peptide conversations, so it's worth being precise: sermorelin is not a weight-loss medication, and Pallas does not prescribe it for weight loss.
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — the signal the body uses to prompt the pituitary gland's own growth hormone release. Unlike the research compounds above, compounded sermorelin can be prescribed by a licensed clinician when clinically appropriate and prepared by state-licensed US compounding pharmacies. It's prescribed for adults for other clinical purposes — what sermorelin is and how it's prescribed is covered on its own page. If a website is selling "sermorelin for fat loss," that's a claim the evidence doesn't support, and a sign to look harder at the seller.
If weight loss is the goal, here's the legitimate path
The evidence-backed, legal route to peptide-class weight-loss treatment runs through a licensed clinician, not a vendor site:
- FDA-approved brand-name medication — Wegovy® or Zepbound®, when a clinician determines it's appropriate. Through Pallas, brand-name medications are cash-pay only and not billed to insurance.
- Compounded semaglutide or tirzepatide — a separate option some clinicians prescribe when a patient-specific clinical reason supports it, prepared per-patient by state-licensed US compounding pharmacies under §503A. At Pallas, compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That price is all-in: clinician care, ongoing check-ins, care-team messaging, and your medication when prescribed.
Either way, the process starts with an online health intake reviewed by a US-licensed clinician — the step every legitimate provider has and every illegitimate one skips. Our guide to getting a GLP-1 prescription online walks through it state by state.
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Talk to a clinician about evidence-backed options
A US-licensed clinician reviews your health history and determines whether a GLP-1 medication is appropriate for you — and tells you honestly if it isn't.
Start your intake →Frequently asked questions
Frequently asked questions
One family does, with FDA approval and large clinical trials behind it: GLP-1 receptor agonists — semaglutide (Wegovy®) and tirzepatide (Zepbound®) — prescribed by a licensed clinician for chronic weight management. The compounds sold online as "weight loss peptides" (BPC-157, AOD-9604, and similar) are not FDA-approved for weight loss, and their human evidence is not established.
The only peptide-class medications FDA-approved for chronic weight management are semaglutide (Wegovy®, Novo Nordisk) and tirzepatide (Zepbound®, Eli Lilly). Which — if either — is appropriate for you is a clinical decision a licensed clinician makes from your health history, not a ranking to shop from. Anything sold without a prescription and a clinician review isn't a contender, whatever its marketing says.
Their safety is not established, and the way they're sold makes it unknowable: "research use only" vials come with no FDA oversight of manufacturing, no verified sterility or dosing, and no licensed pharmacy or clinician accountable for what's actually in them. That risk profile is categorically different from a prescription medication prepared by a licensed, state-regulated pharmacy after a clinician's review.
No. Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), prescribed for adults for other clinical purposes when a licensed clinician determines it's appropriate. It is not a weight-loss medication, and Pallas does not prescribe it for weight loss.
Complete an online health intake that a US-licensed clinician actually reviews. If a GLP-1 medication is appropriate for you, it's prescribed and shipped by a licensed pharmacy. At Pallas, compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That's the all-in price — clinician care, check-ins, messaging, and medication when prescribed.